We are pleased to announce as a new member of the CCCE the company NURALOGIX CORPORATION, based in Toronto, ON, Canada.
NuraLogix™, is an award-winning affective artificial intelligence company and the makers of Anura™, the world’s first contactless wellness and vital signs monitoring solution. Its technology provides instant vital sign measurements and health risk assessments using data collected from a simple 30-second video selfie. Through years of research and development, they have achieved medical-grade accuracy and are supported by peer-reviewed publications and many global clinical collaborations.
The technology behind its innovative products is found in its DeepAffex™ cloud, a cloud-based affective AI platform that uses its proprietary Transdermal Optical Imaging™ (TOI) to provide powerful analysis of physical, physiological, psychological and emotional effects. humans. This enables a comprehensive assessment of a patient’s overall well-being and potential health risks without the need for any device, wearable technology, or anything else besides a smart device, such as a mobile phone, tablet, laptop, or computer. desktop. They are GDPR compliant, hosted on the AWS Frankfurt, Germany cluster for Europe, and are currently in the pipeline with FDA, CE, and other regulators.
Its solution is aimed at different sectors and use cases such as Telehealth; Remote Patient Monitoring; Employee Assistance Programs; Remote Elder Care; Health & Wellness; Insurtech and many more.
They currently work with Sanitas, Quiron Salud, Caser and have many ongoing conversations with Spanish market entities from different sectors.
NURALOGIX CORPORATION expects a good reception in our country and the Spanish entities, since they are aware that Spain is at the forefront of technical innovation and is also very advanced in the digitization of health solutions.
Their solution is key to increasing any value proposition and can make a big difference to a company’s offering as it enables a very simple and seamless tool to obtain vital and health risk parameters.
We are pleased to have a new partner in Medtech/ Healthtech, a sector that is clearly on the rise and where Canada is positioning itself as a leader, with leading companies in this sector. It will be a pleasure for the Chamber to collaborate with NURALOGIX CORPORATION in further developing the Spanish market.